BONO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 1.151
EU - Europa 714
AS - Asia 214
SA - Sud America 51
AF - Africa 11
OC - Oceania 1
Totale 2.142
Nazione #
US - Stati Uniti d'America 1.147
IT - Italia 381
DE - Germania 156
SG - Singapore 109
CN - Cina 56
FI - Finlandia 51
BR - Brasile 44
GB - Regno Unito 24
IN - India 16
SE - Svezia 16
RU - Federazione Russa 15
RO - Romania 13
NL - Olanda 12
IE - Irlanda 11
FR - Francia 10
PK - Pakistan 8
HK - Hong Kong 7
BE - Belgio 6
CI - Costa d'Avorio 5
EG - Egitto 5
AT - Austria 4
IR - Iran 4
TR - Turchia 4
CA - Canada 3
EC - Ecuador 3
PE - Perù 3
UA - Ucraina 3
CZ - Repubblica Ceca 2
IQ - Iraq 2
MO - Macao, regione amministrativa speciale della Cina 2
PL - Polonia 2
PT - Portogallo 2
VN - Vietnam 2
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
CH - Svizzera 1
ES - Italia 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
MX - Messico 1
NP - Nepal 1
SI - Slovenia 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 2.142
Città #
Chandler 155
Ashburn 150
Fairfield 147
Palermo 95
Singapore 81
Woodbridge 77
Munich 63
Wilmington 57
Rome 56
Houston 52
Seattle 52
Helsinki 47
Cambridge 40
Medford 31
New York 31
Ann Arbor 30
Des Moines 28
Princeton 18
Bremen 16
San Diego 14
Lawrence 13
Ludwigshafen am Rhein 13
Kitzingen 11
Beijing 10
Dublin 10
Santa Clara 10
Naples 9
Boardman 8
Kumar 8
Altamura 7
Aversa 7
Council Bluffs 7
Frankfurt am Main 7
London 7
Milan 7
Nuremberg 7
Pune 7
Redwood City 7
Tappahannock 7
Brussels 6
Messina 6
Venice 6
Abidjan 5
Dallas 5
Jinan 5
São Paulo 5
Turin 5
Volla 5
Cagliari 4
Cairo 4
Hebei 4
Lappeenranta 4
Rawalpindi 4
Shenyang 4
Belo Horizonte 3
Changsha 3
Châteauneuf-le-rouge 3
Falls Church 3
Florence 3
Guangzhou 3
Hanover 3
Kilburn 3
Lima 3
Mascalucia 3
Monreale 3
Monza 3
Nanchang 3
Nanjing 3
Potenza 3
San Paolo di Civitate 3
Tehran 3
Agrigento 2
Brasília 2
Brzeg 2
Castelbuono 2
Catania 2
Catanzaro 2
Charlottesville 2
Chieti 2
Colombo 2
Duezce 2
Guarulhos 2
Ho Chi Minh City 2
Juiz de Fora 2
Kiev 2
Lentini 2
Macau 2
Marcallo con Casone 2
Mezzojuso 2
Moscow 2
Napoli 2
Norwalk 2
Osio Sotto 2
Ottawa 2
Phoenix 2
Pisa 2
Quito 2
Reggio Calabria 2
Rio de Janeiro 2
Romainville 2
Totale 1.583
Nome #
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? 189
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 155
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer 148
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 140
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL 127
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 127
Multigene panel testing in Hereditary Breast and Ovarian Cancer: an effective liquid biopsy approach to identify mutations in genes involved in the Homologous Recombination pathway 116
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 110
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming 100
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 100
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 98
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 94
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. 94
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 92
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 86
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients? 66
JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS 63
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 62
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 60
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 48
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 45
Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer 39
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors 36
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family” 25
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study. 25
null 25
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 23
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 22
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? 18
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 16
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors 15
Scientific Communication and oncology – "The bridge between knowledge and patients" 9
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study 7
Totale 2.380
Categoria #
all - tutte 11.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020137 0 0 0 0 0 0 0 4 21 62 39 11
2020/2021440 6 15 21 114 41 39 9 42 43 48 22 40
2021/2022303 29 49 9 18 8 24 10 23 28 34 23 48
2022/2023450 41 61 13 64 38 62 36 43 53 6 16 17
2023/2024341 13 31 22 36 28 63 62 14 7 12 8 45
2024/2025588 36 51 61 58 56 88 190 48 0 0 0 0
Totale 2.380